Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its COVID-19 Booster Vaccine Candidate
First subject vaccinated in Phase 3 clinical trial evaluating potential of the VLP-based candidate, ABNCoV2 as a booster…
First subject vaccinated in Phase 3 clinical trial evaluating potential of the VLP-based candidate, ABNCoV2 as a booster…
Phase 3 Program of IMU-838 in Relapsing-Remitting Multiple Sclerosis Expected to Begin in the Second Half of 2021 Repor…
. - Product shows excellent safety and tolerability - Enables long-term reduction of standard medications and side effec…
With numerous innovations, the Oerlikon Manmade Fibers segment will be presenting itself at the ITMA Asia + CITME betwee…
in conjunction with the WinFors winder, the Oerlikon Barmag spinning system configuration, designed especially for manuf…
At this year’s DOMOTEX Asia / CHINAFLOOR trade show, Oerlikon Neumag will be presenting its diverse range of products an…
Ad19a, the latest in adenoviral (AV) gene vector innovations, has generated first data in preclinical vaccination tests…
With the new WinFors reversing winder, Oerlikon Barmag is expanding its family of winders to include a further member. T…
Konstanz/Germany based contract research organization Trenzyme GmbH and Basel/Switzerland based Celonic AG today announc…
Even today, the average car has around 30 kilograms of textiles, according to the German Textil research board of truste…